Meet Chloe and Olivia Ferro, the sibling co-founders behind SheMed, the UK’s first female-focused GLP-1 telehealth platform. In this interview, they sit down to discuss how they took their own frustrations with a dismissive healthcare system and turned them into a startup that recently raised $50 million at a $1 billion valuation. 00:00 - The Origin Of SheMed & The 16,000-Person Waitlist 03:38 - Live Proctors & Biometrics: The SheMed Screening Process 06:52 - Beyond Weight Loss: GLP-1s for PCOS